News about Diabetes

Call for young innovators: Urban Health Case Challenge in Warsaw, Poland

Are you interested in creating innovative solutions against obesity in urban environments? Be one of the ten UCPH students to compete in the Urban Health Case Challenge in Warsaw, Poland on December 9-12, 2023.

Novo Nordisk buys CBMR biotech spinout to acquire their novel approach for treating obesity and type 2 diabetes

Researchers from University of Copenhagen discovered a target that suppresses hunger, stimulates calorie burning and increases insulin sensitivity. The spinout Embark Biotech has now been acquired by Novo Nordisk

Novo Nordisk køber CBMR-spinoff og ny metode til at behandle fedme og type 2-diabetes

Grundforskere fra Københavns Universitet har opdaget et nyt lægemiddelmål, som hæmmer appetitten, øger kroppens kalorieforbrænding og insulinfølsomhed. Novo Nordisk købt forskernes spinoffselskab, Embark Biotech.

Mysterious hormone makes insulin work better

It makes animals want to eat less and is found in levels 100 times greater in pregnant women. A new study from the University of Copenhagen also reports that it makes insulin work better in rodents. While its role in ou…

Children born from mothers with malaria have a higher risk of developing diabetes

New research from University of Copenhagen have found that babies born from mothers with malaria have a higher risk of developing diabetes as well as other cardio-metabolic diseases.

Medical treatment of fatty liver may be possible thanks to omega-3 fatty acid nanoparticles

Non-alcoholic fatty liver is a widespread disease because of the common occurrences of obesity and type-2 diabetes in Europe, particularly in Denmark.

New affiliated professor in arctic health at University of Copenhagen

University of Copenhagen is appointing medical doctor Michael Lynge Pedersen as the new affiliated professor in artic health at the Department of Public Health.

CBMR secures five-year funding extension from Novo Nordisk Foundation

Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen is awarded up to DKK 1 billion (€134.2 million) from the Novo Nordisk Foundation.

Patients with cancer respond poorly to the hormone insulin

Associate Professor at the Department of Biomedical Sciences, Lykke Sylow, has published a new meta-study showing that cancer patients are at increased risk of metabolic dysfunction.

Anthropological image wins best scientific photo of the year award

The Danish National Research Foundation's award for best scientific photo in 2023 tells the story of a diabetes epidemic that has gone global.

Call for abstracts: Continuity of chronic health care among forcibly displaced persons

University of Copenhagen’s School of Global Health is launching the UCPH Global Health Day on 14 September. The topic for 2023 is ‘Continuity of chronic health care among forcibly displaced persons’.

Bartender model predicts how drugs affect each person

A model based on numerous studies of people with type 2 diabetes can make a new type of prediction: how a certain drug would affect each person at the molecular biological level.

Bartender model predicts how drugs affect each person

A model based on numerous studies of people with type 2 diabetes can make a new type of prediction: how a certain drug would affect each person at the molecular biological level.

"We have miscalculated for decades – half of an insulin dose may not work as expected"

New research suggests that a large portion of a diabetic's insulin dose is unlikely to work as expected. University of Copenhagen researchers have discovered that we have miscalculated insulin behavior for many years.…

ERC awards grant to counteract metabolic diseases

UCPH researcher Zach Gerhart-Hines from the Faculty of Health and Medical Sciences receives the prestigious European Research Council’s Consolidator Grant.

Promise of better treatment for diabetes in Greenland after discovery of widespread genetic variant

An international team of researchers have discovered a new genetic variant that is responsible for close to 7% of all cases of diabetes in Greenland.

“If fixing metabolic diseases was easy, someone would have done it by now”

Associate Professor Jordi Merino relocates from Massachusetts General Hospital, Boston, to start a new group at CBMR that will focus on understanding the molecular mechanisms underlying metabolic disease and response to…

Mexicans should consume less ultra-processed products – especially pregnant women

Ultra-processed products negatively impact Mexican pregnant women, and Mexico could learn a great deal from Denmark when it comes to living a healthier life, says Adriana Granich, a Mexican epidemiologist and medical…

Stung by a scorpion while doing research in Tanzania

Line Hjort studies diabetes and pregnancy, and is working on the Tanzania study. Read more about her research career and motivations here.

Lærke Smidt Gasbjerg receives the Young Researcher Award from the Bagger-Sørensen Foundation

Postdoc Lærke Smidt Gasbjerg has received the Young Researcher Award from the Bagger-Sørensen Foundation for her research in whether gut hormones can be used in the treatment of type 2 diabetes.

Considering the microbiota of mice can dramatically reduce the number of animals to be used in diabetes studies

Globally, there is a call for reducing the number of animals for research. On the other side.....

"It’s really nice to be able to spread my wings and not just work in the lab."

Emilie Glad Bak joined CBMR as a PhD Student working on human microbiomes and viromes, and after she joined SNIPR Biome to setup their Scientific Affairs division.

Jonas Salling Quist has been appointed assistant professor at the Department of Biomedical Sciences

Jonas Salling Quist becomes assistant professor at the Department of Biomedical Sciences. Jonas research addresses prevention and treatment of type 2 diabetes and obesity with a focus on nutrition, physical activity,…

Better diabetes treatment: New insulin molecule can self-regulate blood sugar

Researchers from the University of Copenhagen and biotech firm Gubra have developed a new insulin molecule that will make blood sugar regulation both easier and safer for those with type 1 diabetes.